XML 21 R10.htm IDEA: XBRL DOCUMENT v3.25.3
OTHER (INCOME)/EXPENSE, NET
 9 Months Ended
Sep. 30, 2025
Other Nonoperating Income (Expense) [Abstract]  
OTHER (INCOME)/EXPENSE, NET OTHER (INCOME)/EXPENSE, NET
Three Months Ended September 30,Nine Months Ended September 30,
Dollars in millions2025202420252024
Interest expense
$480 $505 $1,459 $1,451 
Royalty income - divestitures (Note 4)
(286)(284)(844)(820)
Royalty and licensing income (Note 4)(276)(180)(697)(532)
Provision for restructuring (Note 6)75 78 432 558 
Investment income(161)(94)(438)(364)
Integration expenses (Note 6)36 69 110 214 
Litigation and other settlements(a)
165 — 424 71 
Acquisition expense
— — 5 50 
Intangible asset impairment
— 47 — 47 
Equity investment (gains)/losses, net (Note 9)(190)(12)(90)(221)
Contingent consideration (Note 9)
— — 336 — 
Other(b)
48 105 29 134 
Other (income)/expense, net
$(108)$234 $725 $588 
(a)    Reflects charges related to a securities litigation matter during the three months ended September 30, 2025. Additionally, the nine months ended September 30, 2025 includes amounts related to a pricing, sales and promotional practices dispute.
(b)    Includes pension settlement charges of $100 million during the three months ended September 30, 2024 and $119 million during the nine months ended September 30, 2024 incurred in connection with the termination of the Bristol-Myers Squibb Puerto Rico, Inc. Retirement Income pension plan.